Flumazenil

氟马西尼

Report date: 2022/08/08 14:27:50
NME

Base Information

Drug NameFlumazenil
Drug Alias NameFlumazepil氟吗西尼flumazenilflumazenilumMazicon +[10] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGamma-aminobutyric acid A receptor agonists
TargetsGamma-aminobutyric acid A receptor
Therapy Area/IndicationsSedationObsessive-Compulsive DisorderDental Anxiety +[11] 
Global Approved IndicationsSedationHyperemesis Gravidarum
Approved Indications in ChinaHyperemesis Gravidarum
Original Approved Country/TerritoryN/A
Original Approved Date1986/01/01
Country/TerritoryUnited StatesIsraelMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesF. Hoffmann-La Roche Ltd
China Registration ClassN/A

Develop Information

Active CompaniesF. Hoffmann-La Roche LtdUniversity Of MichiganZhejiang Jinhua Aotuokang Pharmaceutical Group Inc Co
Inactive CompaniesYale UniversityStanford UniversityUniversity Of Washington +[5] 
Active IndicationsSedationHyperemesis GravidarumParkinson Disease
Inactive IndicationsObsessive-Compulsive DisorderDental AnxietySubstance-Related Disorders +[8] 

Other Information

ATC CodeV03AB25
Related LinksWikipediaDrugBankKEGG